Rebase Biotech
Duluth, US · Founded 2023 · Delaware corporation
Founders & leadership
SM
SURESH MEREDDYNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$400K disclosed across 1 round · 2023
▶$400KraisedMar 2023 · 5 investors · BiotechnologyRule 506(b)
▶$400KraisedMar 2023 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- SURESH MEREDDYExecutive Officer
- Offering amount
- $1M
- Amount sold
- $400K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Rebase Biotech raised?
- Rebase Biotech has disclosed $400K raised across 1 round.
- Where is Rebase Biotech headquartered?
- Rebase Biotech is headquartered in Duluth, US.